Related Experiment Videos
A mouse model of episodic ataxia type-1
Paco S Herson1, Michael Virk, Nathan R Rustay
1Vollum Institute, Oregon Health & Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA.
Nature Neuroscience
|March 4, 2003
Summary
Episodic ataxia type-1 (EA1) is a neurological disorder caused by Kv1.1 mutations. This study developed a mouse model showing stress-induced motor deficits linked to altered GABA release, offering insights into EA1 pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Channelopathies
Background:
- Episodic ataxia type-1 (EA1) is a dominant neurological disorder.
- EA1 results from mutations in the Kv1.1 potassium channel.
- Affected individuals are heterozygous for the mutation.
Purpose of the Study:
- To create a mouse model of the V408A EA1 mutation.
- To investigate the physiological and behavioral consequences of the V408A mutation.
- To explore the role of GABAergic signaling in EA1-related motor dysfunction.
Main Methods:
- Homologous recombination was used to introduce the V408A mutation into mice.
- Phenotypic analysis of homozygous (V408A/V408A) and heterozygous (V408A/+) mice.
- Electrophysiological recordings of cerebellar Purkinje cells.
- Assessment of spontaneous and miniature inhibitory postsynaptic currents (IPSCs).
Main Results:
- Homozygous V408A/V408A mice exhibited embryonic lethality.
- V408A/+ mice displayed stress-induced motor coordination deficits, responsive to acetazolamide.
- Increased frequency and amplitude of spontaneous GABAergic IPSCs were observed in V408A/+ mice.
- No significant differences in miniature IPSCs or basket cell firing frequency were found.
Conclusions:
- The V408A mouse model recapitulates key features of human EA1, including stress-induced motor dysfunction.
- Altered spontaneous GABA release from cerebellar Purkinje cells is implicated in EA1 pathophysiology.
- This study provides a valuable preclinical model for investigating EA1 treatments.